RLMD icon

Relmada Therapeutics (RLMD)

NASDAQ

$4.56

-$0.050 (

-1.09%

)

1D
5D
1M
6M
1Y
5Y
Market closed

RLMD: $4.56 / ₿ 0.0001 BTC / 7159 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$4.61
$0.24 - $5.12
$334.03M
0.13
$4.60
$276,683.93
73.33M
$4.50 - $5.10
$4.45 - $4.60
Yes

What is Relmada Therapeutics (RLMD)?

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

The Relmada Therapeutics (RLMD) stock price has been falling

The Relmada Therapeutics, Inc. Common Stock (RLMD) stock price today is $4.56, reflecting a -1.09% move since the market opened. The company’s market capitalization stands at $334.03M, with a daily trading volume of $276.68K shares. For investors tracking price trends, Relmada Therapeutics, Inc. Common Stock stock has ranged between $4.45 and $4.60 today. The previous closing price was $4.61.

Get started with Relmada Therapeutics (RLMD)

Ready to get started? Follow the steps below, or read our guide on how to buy Relmada Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy RLMD

Search for RLMD in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy RLMD.

RLMD FAQs

RLMD is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

RLMD is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Relmada Therapeutics, Inc. Common Stock (RLMD) has traded between a low of $0.24 and a high of $5.12.

RLMD is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Relmada Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
RLMD icon
RLMD

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Relmada Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.